Fund Relaunches Trasylol Class Action Against Bayer
A Tennessee benefits fund has taken another shot at filing a proposed class action against Bayer Corp. over alleged fraud in the marketing of the lucrative blood-clotting drug Trasylol, just weeks...To view the full article, register now.
Already a subscriber? Click here to view full article